 Home > Medical News > Latest Medical News > Beihai Biotechnology's third-generation taxane derivative new drug was approved for clinical use

Beihai Biotechnology's third-generation taxane derivative new drug was approved for clinical use

 Last Update: 2021-10-23
 Source: Internet
 Author: User

Tags

boom face products

what drug simvastatin used

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Text|Pharmaceutical Mission Hills

According to the announcement of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration of China, the 2.

Screenshot source: CDE official website

Beihai Biotechnology is a biomedical company in the clinical stage, committed to developing innovative tumor drugs that are patient-centric and have unmet clinical needs

According to the press release of Beihai Biotechnology, cabazitaxel is a second-generation taxane anti-tumor drug, which was first developed by Sanofi and has not yet been listed in China

This time in China, the clinical research indication for BH002 injection approved is "for the treatment of metastatic castration-resistant prostate cancer receiving docetaxel treatment"

Prostate cancer is a high incidence of malignant tumors in men.

According to the press release of Beihai Biotechnology, cabazitaxel has a significant therapeutic effect on mCRPC

Reference materials:

[1] Drug Evaluation Center of China National Medical Products Administration.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.